Role of immunotherapy beyond advanced HCC

Episode 1 August 17, 2022 00:29:42
Role of immunotherapy beyond advanced HCC
COR2ED Medical Education
Role of immunotherapy beyond advanced HCC

Aug 17 2022 | 00:29:42

/

Show Notes

COR2ED Medical Education: In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC).  They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications. 

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode 1

February 28, 2022 00:13:11
Episode Cover

Key topics in HCC discussed at ASCO GI & EASL liver cancer summit 2022

Medical Education podcast by COR2ED. Professor James Harding, HCC Connect member, provides his perspectives and insights on key abstracts and topics discussed at ASCO...

Listen

Episode 2

September 27, 2022 00:21:28
Episode Cover

GI CONNECT Update from ESMO 2022 Ep 2: upper GI cancer highlights

 COR2ED Medical Education: This second GI CONNECT podcast episode, covers the highlights on gastroesophageal cancer from ESMO 2022.  Dr Sam Klempner (Massachusetts General Hospital,...

Listen

Episode 21

September 03, 2023 00:29:25
Episode Cover

Advanced HCC: 2nd line treatment selection and the right time to switch

COR2ED Medical Education: Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at...

Listen